Prosecution Insights
Last updated: August 18, 2026

Examiner: BROWE, DAVID

Tech Center 1600 • Art Units: 1617

This examiner grants 26% of resolved cases

Performance Statistics

26.2%
Allow Rate
-33.8% vs TC avg
796
Total Applications
+27.7%
Interview Lift
1429
Avg Prosecution Days
Based on 729 resolved cases, 2023–2026

Rejection Statute Breakdown

2.6%
§101 Eligibility
6.9%
§102 Novelty
46.7%
§103 Obviousness
32.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18300703 COMPOSITION AND METHODS FOR THE TREATMENT OF PERIPHERAL NERVE INJURY Non-Final OA UNIVERSITY OF ROCHESTER
17627571 COMPOSITE DRUG PARTICLES AND USES THEREOF Final Rejection The Regents of the University of Michigan
19300899 SOFTGEL CAPSULES AND A METHOD FOR PREPARING THE SOFTGEL CAPSULES Non-Final OA R.P. Scherer Technologies, LLC
18940147 FAST DISSOLVING SOFTGEL CAPSULES Non-Final OA R.P. SCHERER TECHNOLOGIES, LLC
16753567 IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME Non-Final OA THE JOHNS HOPKINS UNIVERSITY
18692095 CARE AND/OR MAKEUP COMPOSITION COMPRISING A SILICONE ELASTOMER CONTAINING CARBOXYLIC ACID FUNCTIONS AND A COPOLYMER BASED ON SILICONE RESIN AND ON SILICONE OF DIMETHICONOL TYPE Non-Final OA L'OREAL
18696883 CELLULARIZED NERVE REGENERATION GRAFT AND METHODS OF MAKING THE SAME Non-Final OA Rutgers, The State University of New Jersey
18970662 READY-TO-USE SODIUM BICARBONATE FORMULATIONS AND PRODUCTS Non-Final OA INFORLIFE SA
18713537 METHOD FOR TREATING KERATIN SUBSTANCE OR FIBER FOR HEAD DECORATION PRODUCTS Non-Final OA KAO CORPORATION
18015160 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY Final Rejection SYMRISE AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month